Arora D, Bhatt S, Kumar M, Verma R, Taneja Y, Kaushal N, Tiwari A, Tiwari V, Alexiou A, Albogami S
These medications are for people with more severe PsA
Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo
The metabolic adaptations observed are largely consistent with weight loss achieved through any method, rather than being unique effects of GLP-1 medications themselves
However, consistency is crucial, as results vary by skin type, expect gradual improvements over weeks of dedicated application